Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis
- PMID: 16043017
- DOI: 10.1016/j.freeradbiomed.2005.03.030
Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron degenerative disease characterized by the loss of neuronal function in the motor cortex, brain stem, and spinal cord. Familial ALS cases, accounting for 10-15% of all ALS disease, are caused by a gain-of-function mutation in Cu,Zn-superoxide dismutase (SOD1). Two hypotheses have been proposed to explain the toxic gain of function of mutant SOD (mSOD). One is that mSOD can directly promote reactive oxygen species and reactive nitrogen species generation, whereas the other hypothesis suggests that mSODs are prone to aggregation due to instability or association with other proteins. However, the hypotheses of oxidative stress and protein aggregation are not mutually exclusive. G93A-SOD1 transgenic mice show significantly increased protein carbonyl levels in their spinal cord from 2 to 4 months and eventually develop ALS-like motor neuron disease and die within 5-6 months. Here, we used a parallel proteomics approach to investigate the effect of the G93A-SOD1 mutation on protein oxidation in the spinal cord of G93A-SOD1 transgenic mice. Four proteins in the spinal cord of G93A-SOD1 transgenic mice have higher specific carbonyl levels compared to those of non-transgenic mice. These proteins are SOD1, translationally controlled tumor protein (TCTP), ubiquitin carboxyl-terminal hydrolase-L1 (UCH-L1), and, possibly, alphaB-crystallin. Because oxidative modification can lead to structural alteration and activity decline, our current study suggests that oxidative modification of UCH-L1, TCTP, SOD1, and possibly alphaB-crystallin may play an important role in the neurodegeneration of ALS.
Comment in
-
Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".Free Radic Biol Med. 2007 Jul 15;43(2):157-9. doi: 10.1016/j.freeradbiomed.2007.03.029. Epub 2007 Apr 1. Free Radic Biol Med. 2007. PMID: 17603924 No abstract available.
-
Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".Free Radic Biol Med. 2007 Jul 15;43(2):160-2. doi: 10.1016/j.freeradbiomed.2007.04.012. Epub 2007 Apr 19. Free Radic Biol Med. 2007. PMID: 17603925
-
Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".Free Radic Biol Med. 2007 Jul 15;43(2):163-4. doi: 10.1016/j.freeradbiomed.2007.04.011. Epub 2007 Apr 19. Free Radic Biol Med. 2007. PMID: 17603926 Free PMC article. No abstract available.
Similar articles
-
Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis.J Neurochem. 1998 Nov;71(5):2041-8. doi: 10.1046/j.1471-4159.1998.71052041.x. J Neurochem. 1998. PMID: 9798929
-
Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.Free Radic Biol Med. 2005 Apr 1;38(7):960-8. doi: 10.1016/j.freeradbiomed.2004.12.021. Free Radic Biol Med. 2005. PMID: 15749392
-
Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".Free Radic Biol Med. 2007 Jul 15;43(2):160-2. doi: 10.1016/j.freeradbiomed.2007.04.012. Epub 2007 Apr 19. Free Radic Biol Med. 2007. PMID: 17603925
-
Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.Lab Invest. 1997 Apr;76(4):441-56. Lab Invest. 1997. PMID: 9111507 Review.
-
On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2075-87. doi: 10.1089/ars.2006.8.2075. Antioxid Redox Signal. 2006. PMID: 17034351 Review.
Cited by
-
Redox regulation in amyotrophic lateral sclerosis.Oxid Med Cell Longev. 2013;2013:408681. doi: 10.1155/2013/408681. Epub 2013 Feb 25. Oxid Med Cell Longev. 2013. PMID: 23533690 Free PMC article. Review.
-
Improving image analysis in 2DGE-based redox proteomics by labeling protein carbonyl with fluorescent hydroxylamine.Biol Proced Online. 2007 Dec 19;9:65-72. doi: 10.1251/bpo134. Biol Proced Online. 2007. PMID: 18385803 Free PMC article.
-
Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging.Aging (Albany NY). 2018 May 17;10(5):868-901. doi: 10.18632/aging.101450. Aging (Albany NY). 2018. PMID: 29779015 Free PMC article. Review.
-
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.Cells. 2024 Jan 29;13(3):248. doi: 10.3390/cells13030248. Cells. 2024. PMID: 38334639 Free PMC article. Review.
-
Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction.Biochem J. 2016 Aug 15;473(16):2453-62. doi: 10.1042/BCJ20160082. Biochem J. 2016. PMID: 27515257 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous